- Home
- KXIN vs PALI Comparison
KXIN vs PALI Comparison
Compare KXIN & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- PALI
- Stock Information
- Founded
- KXIN 2015
- PALI 1996
- Country
- KXIN China
- PALI United States
- Employees
- KXIN N/A
- PALI N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KXIN Consumer Discretionary
- PALI Health Care
- Exchange
- KXIN Nasdaq
- PALI Nasdaq
- Market Cap
- KXIN 2.8M
- PALI 3.3M
- IPO Year
- KXIN N/A
- PALI N/A
- Fundamental
- Price
- KXIN $0.83
- PALI $0.69
- Analyst Decision
- KXIN
- PALI Strong Buy
- Analyst Count
- KXIN 0
- PALI 2
- Target Price
- KXIN N/A
- PALI $23.00
- AVG Volume (30 Days)
- KXIN 80.4K
- PALI 700.5K
- Earning Date
- KXIN 01-01-0001
- PALI 05-12-2025
- Dividend Yield
- KXIN N/A
- PALI N/A
- EPS Growth
- KXIN N/A
- PALI N/A
- EPS
- KXIN N/A
- PALI N/A
- Revenue
- KXIN N/A
- PALI N/A
- Revenue This Year
- KXIN N/A
- PALI N/A
- Revenue Next Year
- KXIN N/A
- PALI N/A
- P/E Ratio
- KXIN N/A
- PALI N/A
- Revenue Growth
- KXIN N/A
- PALI N/A
- 52 Week Low
- KXIN $0.64
- PALI $0.60
- 52 Week High
- KXIN $29.52
- PALI $9.65
- Technical
- Relative Strength Index (RSI)
- KXIN 19.47
- PALI 38.10
- Support Level
- KXIN $0.90
- PALI $0.60
- Resistance Level
- KXIN $0.96
- PALI $0.73
- Average True Range (ATR)
- KXIN 0.08
- PALI 0.06
- MACD
- KXIN -0.00
- PALI 0.01
- Stochastic Oscillator
- KXIN 48.14
- PALI 39.23
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.